Ignite Creation Date:
2024-05-06 @ 3:52 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02390297
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-08
First Post:
2015-03-11
Brief Title:
Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients
Sponsor:
Calimmune Inc
Organization:
Calimmune Inc
Study Overview
Official Title:
Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4 T Lymphocytes andor CD34 Hematopoietic StemProgenitor Cells Transduced With LVsh5C46 a Dual Anti-HIV Gene Transfer Construct
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Long term safety follow-up of Cal-1 recipients
Detailed Description:
Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4 T Lymphocytes andor CD34 Hematopoietic StemProgenitor Cells Transduced with LVsh5C46 Cal-1 a Dual Anti-HIV Gene Transfer Construct
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None